Tesla Targets Europe's Value Buyers With New Long Range Model Y — Positive
TSLA Zacks Investment Research — January 13, 2026Tesla launches Model Y Standard Long Range RWD in Europe pairing long range, efficiency and lower pricing.
ADMA Biologics Reports Preliminary 2025 Results, Ups 2026 Outlook — Positive
ADMA Zacks Investment Research — January 13, 2026ADMA expects 2025 revenues of approximately $510-$511 million, raising 2026 guidance on strong Asceniv demand and margin expansion.
Can VLO Continue to Earn From Ongoing Softness in Oil Price? — Neutral
VLO Zacks Investment Research — January 13, 2026Valero stands to gain as crude prices stay soft, lifting refining margins, strengthening its balance sheet and supporting dividends and buybacks.
Ronald A. Homer Steps Down as Chair, Jair Lynch Elected as New Board Chair Ronald A. Homer Steps Down as Chair, Jair Lynch Elected as New Board Chair
Japan stocks and the related ETFs are coming off scintillating performances in 2025. They currently rank among the best performers in developed markets.
Not even two full trading weeks into 2026 and the good news is already piling up for a slew of big name technology stocks. That brings benefits to investors engaged with the tech-heavy Invesco QQQ Trust (QQQ) and the Invesco NASDAQ 100 ETF (QQQM).
NUKZ: Bridging the Accessibility Gap in the Global Nuclear Renaissance — Neutral
NUKZ ETF Trends — January 13, 2026The global shift toward decarbonization and the explosive growth of artificial intelligence (AI) have positioned nuclear energy as a critical component of the future energy mix. For financial advisors, capturing this thematic shift has historically been a logistical challenge.
Tesla's EV market share soars in the US as rivals struggle without government help — Positive
TSLA Business Insider — January 13, 2026Tesla leads the US electric vehicle market with a 59% share, after the end of federal incentives. Ford, Rivian, and General Motors struggle with low EV market share and profitability issues.
EyePoint, Inc. (EYPT) Presents at 44th Annual J.P. Morgan Healthcare Conference Transcript — Neutral
EYPT Seeking Alpha — January 13, 2026EyePoint, Inc. (EYPT) Presents at 44th Annual J.P. Morgan Healthcare Conference Transcript
Progyny, Inc. (PGNY) Presents at 44th Annual J.P. Morgan Healthcare Conference Transcript — Neutral
PGNY Seeking Alpha — January 13, 2026Progyny, Inc. (PGNY) Presents at 44th Annual J.P. Morgan Healthcare Conference Transcript
Illumina, Inc. (ILMN) Presents at 44th Annual J.P. Morgan Healthcare Conference Transcript — Neutral
ILMN Seeking Alpha — January 13, 2026Illumina, Inc. (ILMN) Presents at 44th Annual J.P. Morgan Healthcare Conference Transcript
COREWEAVE, INC. (NASDAQ: CRWV) INVESTOR ALERT Investors With Large Losses in CoreWeave, Inc. Should Contact Bernstein Liebhard LLP To Discuss Their Rights — Neutral
CRWV GlobeNewsWire — January 13, 2026NEW YORK, Jan. 13, 2026 (GLOBE NEWSWIRE) -- Bernstein Liebhard LLP announces that a shareholder has filed a securities class action lawsuit on behalf of investors (the “Class”) who purchased or acquired the securities of CoreWeave, Inc. (“CoreWeave” or the “Company”) (NASDAQ: CRWV) between March 28 , 202 5 and Decem ber 15 , 202 5, inclusive. For more information, submit a form at CoreWeave, Inc. Shareholder Class Action Lawsuit, email Investor Relations Manager Peter Allocco at [email protected], or call us at (212) 951-2030.
KLARNA GROUP PLC (NYSE: KLAR) INVESTOR ALERT: Investors With Large Losses in Klarna Group plc Should Contact Bernstein Liebhard LLP To Discuss Their Rights — Neutral
KLAR GlobeNewsWire — January 13, 2026NEW YORK, Jan. 13, 2026 (GLOBE NEWSWIRE) -- Bernstein Liebhard LLP announces that a shareholder has filed a securities class action lawsuit on behalf of investors (the “Class”) who purchased or otherwise acquired Klarna Group plc (“Klarna” or the “Company”) (NYSE: KLAR) securities pursuant and/or traceable to the registration statement and related prospectus (collectively, the “Registration Statement”) issued in connection with the Company's September 2025 initial public offering (the “IPO”). For more information, submit a form at Klarna Group plc Shareholder Class Action Lawsuit, email Investor Relations Manager Peter Allocco at [email protected], or call us at (212) 951-2030.
MCHP Rises 29% in a Year: How Should You Approach the Stock in 2026? — Positive
MCHP Zacks Investment Research — January 13, 2026Microchip gains from AI momentum, product launches and a revised sales outlook signaling end-market recovery.
First Horizon Earnings Are Imminent; These Most Accurate Analysts Revise Forecasts Ahead Of Earnings Call — Neutral
FHN Benzinga — January 13, 2026First Horizon Corporation (NYSE: FHN) will release earnings results for the fourth quarter, before the opening bell on Thursday, Jan. 15.
VARONIS SYSTEMS, INC. (NASDAQ: VRNS) INVESTOR ALERT: Investors With Large Losses in Varonis Systems, Inc. Should Contact Bernstein Liebhard LLP To Discuss Their Rights — Neutral
VRNS GlobeNewsWire — January 13, 2026NEW YORK, Jan. 13, 2026 (GLOBE NEWSWIRE) -- Bernstein Liebhard LLP announces that a shareholder has filed a securities class action lawsuit on behalf of investors (the “Class”) who purchased or acquired the common stock of Varonis Systems, Inc. (“Varonis” or the “Company”) (NASDAQ: VRNS) between February 4 , 202 5 and October 28 , 202 5, inclusive. For more information, submit a form at Varonis Systems, Inc. Shareholder Class Action Lawsuit, email Investor Relations Manager Peter Allocco at [email protected], or call us at (212) 951-2030.
Nvidia's stock was just named a top pick for a reason that might be surprising — Positive
NVDA Market Watch — January 13, 2026The chip giant's stock has actually been an AI laggard lately, creating opportunity for investors.
Delta Air Lines, Inc. reported solid Q4 results, guiding for 20% EPS growth in 2026, but remains challenged to break past a $7 EPS ceiling. DAL is in a strong financial position with robust free cash flow and a strengthened balance sheet with $35B in unencumbered assets. Despite record revenues and double-digit ROIC, persistent cost pressures and labor expenses hinder the airline from pushing EPS above the constant $7 target.
Ionis Pharmaceuticals, Inc. (IONS) Presents at 44th Annual J.P. Morgan Healthcare Conference Transcript — Neutral
IONS Seeking Alpha — January 13, 2026Ionis Pharmaceuticals, Inc. (IONS) Presents at 44th Annual J.P. Morgan Healthcare Conference Transcript
UiPath Inc. (PATH) Presents at 28th Annual Needham Growth Conference Transcript — Neutral
PATH Seeking Alpha — January 13, 2026UiPath Inc. (PATH) Presents at 28th Annual Needham Growth Conference Transcript